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Introduction: We report on the successful endovascular treatment of a ruptured splenic artery pseudoaneurysm.
Our patient had acute pancreatitis superimposed on chronic calcific pancreatitis and chronic renal impairment.
Contrast-enhanced ultrasonography was used to assess post-embolization results.
Case presentation: Our patient was a 67-year-old white Caucasian man with recurrent pancreatitis. Computed
tomography angiography showed a pancreatic pseudocyst with a ruptured pseudoaneurysm, which was successfully
embolized using an endovascular percutaneous approach. At six months, persistent renal failure led to
contrast-enhanced ultrasonography. This confirmed the absence of turbulent blood flow and extravasation of
contrast medium in the pseudocyst.
Conclusion: Our experience with this case leads us to support the role of interventional radiology as a first-line
treatment tool. Contrast-enhanced ultrasonography can be used to follow-up embolization procedures in
patients with impaired renal function.
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Severe pancreatic inflammation and necrosis, which
cause the local spread of pancreatic fluids rich in exo-
crine enzymes, may cause elastolytic erosions of the ves-
sel wall, representing one of the causes of vessel injury
[1-4]. This can lead to vascular complications, such as
the formation of a pseudoaneurysm if there is bleeding
into a contained space or organ, a contained hematoma
if the pseudoaneurysm becomes thrombosed or active
extravasation stops, or frank intraperitoneal hemorrhage
if the pseudoaneurysm ruptures. Pancreatic pseudoa-
neurysm (PSA) is a rare vascular complication of pan-
creatitis, with an incidence up to 10% in patients with
chronic disease. It commonly results from the erosion of
the pancreatic or peripancreatic arteries into a pseudocyst,* Correspondence: gcarraf@gmail.com
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unless otherwise stated.creating a permanent communication between the vascu-
lature and the pseudocyst itself [1].
In the setting of chronic pancreatitis causing pseudoa-
neurysm, the most commonly involved artery is the
splenic artery (60% to 65%), followed by gastroduodenal
(20% to 25%), pancreaticoduodenal (10% to 15%), hep-
atic (5% to 10%) and left gastric arteries (2% to 5%). Less
frequently involved are the dorsal pancreatic, hepatic
and superior mesenteric arteries [2]. These vascular
complications may have an unpredictable evolution and
can have lethal consequences caused by rupture and
massive bleeding. Mortality can be 12.5% in treated pa-
tients and higher than 90% in untreated patients [3,5].
Historically, pseudoaneurysms secondary to pancreatitis
were treated surgically, with an associated mortality of
approximately 56%. Thanks to the advances in interven-
tional radiological techniques, the paradigm has largely
shifted towards endovascular treatment.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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PSA in a patient with acute pancreatitis superimposed
on chronic calcific pancreatitis and renal impairment.
Our experience with this case leads us to support the
first-line role of urgent endovascular ligature confirmed
by the use of contrast-enhanced ultrasonography (CEUS)
in patients with impaired renal function [6]. The report
has been approved by our Internal Review Board and
our patient has given his consent.
Case presentation
A 67-year-old white Caucasian man with chronic pan-
creatitis, cholelithiasis and impaired renal function pre-
sented to our emergency department for anorexia and
moderate to intense pain in his epigastrium radiating to
his back. His usual analgesics had not lessened the pain,
which had worsened in the previous four days. On phys-
ical examination he was cachectic, pale, oriented and
apyretic (36.8°C). He had normal heart sounds (78 beats
per minute) and a slightly high arterial pressure (147/
80mmHg). His abdomen was particularly tender in the
left upper epigastric area and the tenderness increased
with palpation. Laboratory tests revealed the following
data: leukocytosis at 11×10−3/μL, low hemoglobin level
of 8.1g/dL, platelet count of 258×10−3/μL, serum cre-
atinine of 2.35mg/dL, lipase level of 420IU/L, amylase of
220IU/L, lactate dehydrogenase of 450IU/L, glucose of
76mg/dL, aspartate aminotransferase of 45IU/L and total
bilirubin of 1.1mg/dL. He had no history of previous
upper gastrointestinal bleeding.
We performed contrast-enhanced computed tomog-
raphy (CECT), which showed a normally enhancingFigure 1 Initial radiology findings. (a) Non-enhanced computed tomog
(asterisk) near a 5.1cm pseudocyst with hyper-dense content and a gallston
tomography shows a pseudoaneurysm arising from a splenic artery branchpancreas, with enhancement comparable to that of his
spleen even though the head and body of the pancreas
were slightly enlarged with subtle peripheral fat-stranding.
Prior to contrast medium (CM) administration, subtle cal-
cifications had been visible throughout the pancreas body.
These findings were suggestive of edematous, interstitial
pancreatitis superimposed on chronic calcific pancreatitis.
A 5.1cm pseudocyst was visible in the pancreatic tail, char-
acterized by hyper-dense content in the non-enhanced
contrast scan (mean density 54 Hounsfield units, standard
deviation 13.8), that did not enhance after CM administra-
tion. We first suspected proteinaceous content, but then
detected enlarged, twisty, dilated vessels within the cyst,
arising from a branch of the patient’s splenic artery. This
was highly suspicious for the presence of a bleeding pan-
creatic PSA. On the basis of the density values of the
pseudocyst without and after intravenous CM administra-
tion (Figure 1a-d), we could not exclude a recent bleed.
The possibility of surgical hemostasis was discarded by
surgeons because of his multiple severe systemic illnesses
and very poor general performance. He had severe pul-
monary hypertension due to an advanced idiopathic in-
terstitial fibrosis, and severe impaired renal function
(estimated glomerular filtration rate (eGFR) using the
Modification of Diet in Renal Disease (MDRD)a = 28mL/
min/1.73m2. Because of his low hemoglobin level, an
emergency celiac angiography was planned after collegial
discussion with surgeons to exclude an active bleeding
arising from the PSA. A splenic angiogram showed an
active extravasation of CM originating from the PSA,
which showed well after a super-selective catheterization
obtained with a 2.7-F coaxial micro-catheter (Progreat,raphy showing a thin, dense imbibition of fat around the pancreatic tail
e inside the gallbladder (arrow). (b-d) Contrast-enhanced computed
inside the pseudocyst.
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ture was tried as first-line therapy. Considering the tortu-
osity of his splenic artery, the micro-catheter was placed
into his splenic artery distal to the pseudoaneurysm to
achieve distal embolization with three (two 5mm and
one 6mm) metallic microcoils (VortX; Boston Scientific,
Natick, MA, USA). After micro-catheter retraction
proximal to the pseudoaneurysm, two (one 5mm and
one 6mm) metallic microcoils (VortX) were deployed
(Figure 2a-d). Angiography after endovascular ligature
showed exclusion of the PSA with stagnation of CM
within the pseudocyst (Figure 2a-d).
Our patient’s clinical course was acceptable with pro-
gressive hemoglobin recovery up to 11.4g/dL 48h after
the transarterial embolization. Wide-spectrum antibi-
otics and analgesic and antipyretic drugs were adminis-
trated to prevent infectious complications and to control
pain. Six days after the procedure, CECT confirmed the
complete exclusion of the splenic pseudoaneurysm with
the same ‘stagnation’ of CM (Figure 3a-c) that was ap-
preciable on the post-embolization angiogram. Some is-
chemic damage of the spleen was identified, but most of
the splenic parenchymal vascularization was present.
Our patient was discharged in a stable condition. Follow-
up at three and six months comprised combined color
Doppler ultrasound with CEUS using a dedicated CMFigure 2 Angiogram images. (a) Multiplanar reformation reconstructions
splenic artery branch. (b,c) Selective and super-selective angiogram confirm
showed the presence of distal and proximal metallic microcoils after their d(Sonovue, Bracco, Italy) (Figure 4a-c) because of the per-
sistent elevation of his serum creatinine levels (1.7mg/dL
and eGFR with MDRD = 40mL/min/1.73m2). This choice
was concordant with European Society of Urogenital Radi-
ology (ESUR) guidelines [6] to consider an imaging method
that does not use iodine-based CM in order to reduce the
risk of a CM-induced nephropathy (CIN) in a patient at
high risk (eGFR lower than 45mL/min/1.73m2). Both ex-
aminations confirmed the presence of a pancreatic pseudo-
cyst with a slightly increased diameter (60mm) without
signs of active bleeding inside the cyst (Figure 4a-c).
Discussion
Hemorrhage is a rare but potentially fatal complication
in pancreatitis, with a greater incidence observed in
chronic disease (7% to 10%) than in acute (1% to 6%) [2].
Pseudoaneurysms may cause bleeding if they rupture into
the peritoneal cavity, retroperitoneum or adjacent struc-
tures, such as bowel (presenting as massive gastrointestinal
hemorrhage) or pancreatic duct of Wirsung (presenting as
hemosuccus pancreaticus) [4]. In the detection of vascular
injuries due to pancreatitis, CECT and, less frequently,
ultrasonography (US) represent non-invasive and suitable
first-line imaging modalities. In our case, CECT detected
the presence of a PSA, while angiography revealed its
bleeding and permitted its embolization. One significantdemonstrating a pseudoaneurysm arising from an inferior polar
ing the pseudoaneurysm and its bleeding (arrow). (d) Final angiogram
eployment.
Figure 3 Post-endovascular ligature computed tomography
images. Computed tomography performed (a) without intravenous
contrast medium administration and (b,c) after administration shows
microcoils deployed in the splenic artery, with stagnation of contrast
medium inside the pseudocyst (asterisks in a) and exclusion of the
pseudoaneurysm in the arterial (b) and venous (c) phase.
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bed in real-time, allowing an assessment of the vascular
supply and collateral circulation. This information is re-
quired to plan treatment. Moreover, angiography mayidentify other smaller pseudoaneurysms not seen by US or
CECT. It can also help discriminate PSA from other le-
sions, such as true aneurysms, arteriovenous fistulas and
vascular malformations, which can have similar appear-
ances on other imaging modalities. Because of its high
sensitivity (100%) in the detection of arterial bleeding, angi-
ography remains the diagnostic gold standard when endo-
vascular treatment is indicated [2-6].
The natural course of PSA is unpredictable, and so
treatment is recommended [5]. In the management of
PSAs several factors have to be considered, including
hemodynamic stability, coagulation status and source of
bleeding. Traditionally, surgery was the treatment of choice,
including arterial ligation, direct intra-pseudocystic ligation,
and resection of a part of the pancreas. The morbidity of
surgical interventions has been reported between 16% and
50% [2]. With the advancement of endovascular techniques,
endovascular ligature has become the first-line treatment
[2]. In some cases, transarterial catheter embolization can
be performed before surgery to stop bleeding, as surgery
sometimes is not indicated in emergent conditions in pa-
tients with hemodynamic instability and hemorrhagic shock
[5]. However, endovascular therapy remains the first-line
option for known arterial bleeding (preferably in a patient
with a stable hemodynamic status) and is considered a safe
and effective modality to treat visceral pseudoaneurysms
[4,7]. Metallic coil embolization is preferable distal and
proximal to the site of arterial extravasation (the so-called
sandwich technique, or endovascular ligature), thereby pre-
venting backflow from the collateral circulation [4,7,8]. Ac-
cording to data in the literature, endovascular ligature was
the fastest way to arrest bleeding in our patient and may be
considered a life-saving procedure. We controlled ischemic
damage of the spleen allowing the revascularization of the
splenic parenchyma by collateral branches. Any infectious
complications were prevented with antibiotic prophylaxis.
An important aspect emerging in the follow-up of a li-
gated PSA in a patient with impaired renal function is
the choice of CEUS. According to ESUR guidelines [6],
in the planning of elective examinations, it is mandatory
to select an imaging method that does not use iodine-
based contrast in a patient at high risk for a CIN.
Adverse events (such as nephropathy) for sonographic
contrast agents have not been reported in the literature
[6,9-11]. Our experience with this case underlines the
rare possibility of a vascular complication in a patient
with chronic pancreatitis. When clinical data and labora-
tory tests are suggestive for a vascular complication, an
urgent diagnosis is necessary. An early diagnosis may be
life-saving for the patient. An endovascular approach is
now usually the first choice of treatment; another aspect
to bear in mind is the importance of an endovascular
ligature of the PSA to account for the presence of
multiple collateral branches that may refill the PSA.
Figure 4 Contrast-enhanced ultrasonography performed after six months. (a-c) Shows the presence of deployed metallic microcoils
(arrowheads, a-c) and the absence of reperfusion of the pseudocyst after intravenous contrast medium administration.
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tomatic and stable patients should be emphasized.Conclusion
Our case represents an example of successful manage-
ment of a rare vascular complication in a patient with
chronic pancreatitis and several important comorbidities.
Our experience supports the first-line role of interven-
tional radiology, and demonstrated a successful outcome
of an endovascular ligature without the need for surgery.
We encourage the use of CEUS to follow-up embolization
procedures in patients with impaired renal function.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.Endnote
aFor the MDRD formula, see http://mdrd.com/.
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